Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | KSQ-004EX |
Synonyms | |
Therapy Description |
KSQ-004EX comprises autologous tumor infiltrating lymphocytes (TILs) engineered to harbor inactivation of SOCS1 and Regnase-1, which potentially induces cytotoxicity in tumor cells and enhances antitumor immune response (Journal for ImmunoTherapy of Cancer 2024;12). |